+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 20Years - 29Years
All Genders
ID07418827

Study on Healthcare Adherence and Transition to Adulthood in Young Adults with Severe Haemophilia TRANSHEMO 2 Longitudinal Study

Led by Assistance Publique Hopitaux De Marseille · Updated on 2026-10-08

75

Participants Needed

25

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adolescents and young adults with severe haemophilia to understand how well they stick to their healthcare routines as they transition from adolescence to adulthood. This study builds on a previous cross-sectional study called TRANSHEMO, which found that young adults tend to have lower adherence to healthcare management than adolescents. The new study, TRANSHEMO 2, uses a longitudinal design to better identify factors that influence sustained adherence over time during this important life transition. Participants are young adults aged 20 to 29 years who have severe haemophilia and previously took part in the TRANSHEMO project as adolescents. The study involves completing questionnaires to collect information on healthcare adherence and related factors. This observational study does not involve treatment interventions but focuses on gathering data to compare adherence before and after transition to adult care. During the study, researchers will collect data on the number of follow-up visits, adherence to clinical follow-up and treatment, number of haemorrhagic events, and other health-related outcomes using registry information and participant reports. Additional analyses will explore quality of life, coping strategies, autonomy, and family functioning. The study aims to last until June 2027, with primary outcome data collected around December 2026, providing insights into how adherence changes and what influences it during the transition to adulthood.

CONDITIONS

Brief Title

Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

Research Team

N

Noémie Resseguier, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here